Healthcare Global Enterprises · NSE: HCG · BSE: 539787
Q1 FY23 results · Apr–Jun 2022
Healthcare Global Enterprises reported revenue from operations of ₹408.05 crore (up 26.3% from Q1 FY22) and net profit of ₹2.48 crore for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 408.05 | 323.14 | +26.3% | 364.63 | +11.9% |
| Other income | 2.91 | 3.44 | −15.4% | 3.01 | −3.3% |
| Total income | 410.96 | 326.58 | +25.8% | 367.64 | +11.8% |
| Profit before tax | 10.42 | (9.49) | Turned profit | 0.92 | 11x |
| Net profit for the period | 2.48 | (12.52) | Turned profit | 2.25 | +10.2% |
| Attributable to shareholders of the company | 6.05 | (9.57) | Turned profit | 5.99 | +1.0% |
| EPS, basic (₹) | 0.44 | (0.76) | not comparable | 0.43 | +2.3% |
| Net margin (%) | 0.6 | -3.9 | 0.6 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 243.17 | 200.60 | +21.2% | 220.19 | +10.4% |
| Other income | 1.87 | 4.53 | −58.7% | 2.25 | −16.9% |
| Total income | 245.04 | 205.13 | +19.5% | 222.44 | +10.2% |
| Profit before tax | 16.41 | 1.93 | +750.3% | (15.73) | Turned profit |
| Net profit for the period | 10.85 | 1.40 | +675.0% | (17.92) | Turned profit |
| EPS, basic (₹) | 0.78 | 0.11 | not comparable | (1.29) | Turned profit |
| Net margin (%) | 4.5 | 0.7 | -8.1 |
Consolidated
- Filed with BSE
- 11 Aug 2022, 14:37 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2022, 14:37 IST
- Board meeting
- 10 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE